Clinical Pathological Characteristics And Initial Treatment Of Primary Focal Segmental Glomerulosclerosis In Chinese Patients
Yifan Shi,Jingyuan Xie,Yunzi Liu,Li Lin,Jianni Huang,Xiaoxia Pan,Jing Xu,Hong Ren,Nan Chen
2019-01-01
Abstract:Background: Few studies have focused on the clinical pathological features and initial treatment of focal segmental glomerulosclerosis (FSGS) in Asian populations. There is a lack of large-sample-size retrospective studies of primary FSGS in Chinese patients. Methods: This retrospective study included 808 patients diagnosed with primary FSGS, between January 2003 until December 2017. This study aimed to explore the prevalence of pathological and clinical features of primary FSGS over the past 15 years, as well as characteristics of each variant under the Columbia classification, a recognized pathological classification. A total of 361 patients were classified by the Columbia classification, of which 277 underwent regular follow-ups (6 months - 60 months). According to follow-up data, the current study summed up the best initial treatment based on proteinuria and Columbia classification. Results: As the years have progressed, the proportion of pFSGS patients, among all renal biopsy patients, has decreased gradually. Detection rates of 2003-2007, 2008-2012, and 2013-2017 were, respectively, 14.7%, 9.7%, and 7.9%. The proportion of pFSGS patients, among primary glomerular disease (PGD), has also decreased, respectively 22.5%, 14.5%, and 11.1%. Over time, the proportion of glomerular segmental sclerosis has gradually decreased, while the proportion of glomerular global sclerosis has gradually increased. In the current study, NOS showed the highest prevalence of (73.6%), followed by perihilar (14.1%), tip (9.2%), and collapsing variants (2.5%). Cellular variants had the lowest prevalence (0.6%). Present results showed that, in Perihilar with moderate proteinuria, simple ACEI/ARB, as an initial treatment, can bring satisfactory remission rates. Regarding NOS and tip, ACEI/ARB combined with steroids can lead to better remission rates. For Tip with severe proteinuria, steroids alone are able to obtain satisfactory remission rates. With NOS, remission rates of steroids + CTX are better than those of steroids alone or steroids + CNIs. Conclusion: Over the past 15 years, FSGS detection rates of renal biopsies and PGD have shown a downward trend. Over time, the proportion of glomerular segmental sclerosis has gradually decreased, while the proportion of glomerular global sclerosis has gradually increased, with aging as an independent factor in this trend. In choosing an initial treatment, the combination of both proteinuria and Columbia classification may bring higher remission rates.